ArticleDiabetes, obesity & metabolism2026

If treating obesity with GLP-1-based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials.

Anastasios Tentolouris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.